CIK 0000096943
- Large accelerated filer
TELEFLEX INC
Sign in to watch- Ticker
- TFX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 231147939
- Phone
- +1 610-225-6800
- Business address
- 550 E SWEDESFORD RD, SUITE 400, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-15 | Hicks Cameron P Vice President, Global HR | Exercise or conversion | +1,000 | $85.54 | $86K | 7,376.02 |
| 2019-08-15 | Hicks Cameron P Vice President, Global HR | Sale | −1,000 | $370.00 | $370K | 6,376.02 |
| 2019-08-15 | Hicks Cameron P Vice President, Global HR | Exercise or conversion · Stock Option / (Right to Buy) | −1,000 | 7,192 | ||
| 2019-08-14 | Deren John VP & Chief Accounting Officer | Exercise or conversion | +632 | $194.40 | $123K | 3,046 |
| 2019-08-14 | Deren John VP & Chief Accounting Officer | Exercise or conversion | +969 | $253.72 | $246K | 4,015 |
| 2019-08-14 | Deren John VP & Chief Accounting Officer | Sale | −1,601 | $364.95 | $584K | 2,414 |
| 2019-08-14 | Deren John VP & Chief Accounting Officer | Sale | −403 | $365.53 | $147K | 2,011 |
| 2019-08-14 | Deren John VP & Chief Accounting Officer | Exercise or conversion · Stock Option / (Right to Buy) | −632 | 316 | ||
| 2019-08-14 | Deren John VP & Chief Accounting Officer | Exercise or conversion · Stock Option / (Right to Buy) | −969 | 1,939 | ||
| 2019-07-25 | Klasko Stephen K. M.D. Director | Exercise or conversion | +200 | $61.34 | $12K | 936 |
| 2019-07-25 | Klasko Stephen K. M.D. Director | Sale | −200 | $343.28 | $69K | 736 |
| 2019-07-25 | Klasko Stephen K. M.D. Director | Exercise or conversion · Stock Option / (Right to Buy) | −200 | 1,000 | ||
| 2019-07-17 | SMITH BENSON Director | Exercise or conversion | +8,500 | $59.75 | $508K | 85,299.98 |
| 2019-07-17 | SMITH BENSON Director | Sale | −1,900 | $332.06 | $631K | 83,399.98 |
| 2019-07-17 | SMITH BENSON Director | Sale | −6,600 | $332.82 | $2.2M | 76,799.98 |
| 2019-07-17 | SMITH BENSON Director | Exercise or conversion · Stock Option / (Right to Buy) | −8,500 | 33,981 | ||
| 2019-07-03 | SMITH BENSON Director | Exercise or conversion | +8,500 | $59.75 | $508K | 85,299.98 |
| 2019-07-03 | SMITH BENSON Director | Sale | −2,200 | $331.43 | $729K | 83,099.98 |
| 2019-07-03 | SMITH BENSON Director | Sale | −6,200 | $332.06 | $2.1M | 76,899.98 |
| 2019-07-03 | SMITH BENSON Director | Sale | −100 | $332.72 | $33K | 76,799.98 |
Page 30 of 45 · 899 trades